Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
J Lipid Res ; 59(9): 1640-1648, 2018 09.
Artículo en Inglés | MEDLINE | ID: mdl-30021760

RESUMEN

Abetalipoproteinemia (ABL) and chylomicron retention disease (CMRD) are extremely rare recessive forms of hypobetalipoproteinemia characterized by intestinal lipid malabsorption and severe vitamin E deficiency. Vitamin E is often supplemented in the form of fat-soluble vitamin E acetate, but fat malabsorption considerably limits correction of the deficiency. In this crossover study, we administered two different forms of vitamin E, tocofersolan (a water-soluble derivative of RRR-α-tocopherol) and α-tocopherol acetate, to three patients with ABL and four patients with CMRD. The aims of this study were to evaluate the intestinal absorption characteristics of tocofersolan versus α-tocopherol acetate by measuring the plasma concentrations of α-tocopherol over time after a single oral load and to compare efficacy by evaluating the ability of each formulation to restore vitamin E storage after 4 months of treatment. In patients with ABL, tocofersolan and α-tocopherol acetate bioavailabilities were extremely low (2.8% and 3.1%, respectively). In contrast, bioavailabilities were higher in patients with CMRD (tocofersolan, 24.7%; α-tocopherol acetate, 11.4%). Plasma concentrations of α-tocopherol at 4 months were not significantly different by formulation type in ABL or CMRD. This study provides new insights about vitamin E status in ABL and CMRD and suggests the potential of different formulations as treatment options.


Asunto(s)
Abetalipoproteinemia/metabolismo , Hipobetalipoproteinemias/metabolismo , Síndromes de Malabsorción/metabolismo , Vitamina E/farmacocinética , alfa-Tocoferol/farmacocinética , Adulto , Disponibilidad Biológica , Estudios de Casos y Controles , Composición de Medicamentos , Almacenaje de Medicamentos , Femenino , Humanos , Absorción Intestinal , Masculino , Persona de Mediana Edad , Seguridad , Vitamina E/sangre , Vitamina E/metabolismo , alfa-Tocoferol/sangre , alfa-Tocoferol/metabolismo
2.
J Pediatr Endocrinol Metab ; 25(11-12): 1191-4, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-23329770

RESUMEN

Chylomicron retention disease (CRD), or Anderson disease, is a rare, hereditary cause of fat malabsorption. It is one of the familial hypocholesterolaemia syndromes, along with homozygous hypobetalipoproteinaemia (HBL) and abetalipoproteinaemia (ABL). We report clinical, laboratory and histological data as well as molecular DNA analysis in the case of a 4-month-old boy with failure to thrive and steatorrhea who was diagnosed with CRD. His mother's first cousin, who was diagnosed as hypobetalipoproteinaemia 30 years ago, was also reviewed and his diagnosis was revised to CRD. Both patients were treated with a low fat diet and supplementation with fat-soluble vitamins resulting in significant improvement. In conclusion, CRD is a well-defined cause of fat malabsorption and can be distinguished from other forms of familial hypocholesterolaemia because of its specific lipid profile.


Asunto(s)
Quilomicrones/metabolismo , Insuficiencia de Crecimiento/diagnóstico , Trastornos del Crecimiento/diagnóstico , Trastornos del Metabolismo de los Lípidos/diagnóstico , Síndromes de Malabsorción/diagnóstico , Dieta con Restricción de Grasas , Suplementos Dietéticos , Duodeno/patología , Duodeno/ultraestructura , Endoscopía Gastrointestinal , Insuficiencia de Crecimiento/genética , Insuficiencia de Crecimiento/metabolismo , Salud de la Familia , Trastornos del Crecimiento/genética , Trastornos del Crecimiento/metabolismo , Humanos , Lactante , Trastornos del Metabolismo de los Lípidos/genética , Trastornos del Metabolismo de los Lípidos/metabolismo , Síndromes de Malabsorción/genética , Síndromes de Malabsorción/metabolismo , Masculino , Esteatorrea/diagnóstico , Esteatorrea/genética , Esteatorrea/metabolismo , Vitaminas/administración & dosificación
3.
Orphanet J Rare Dis ; 5: 24, 2010 Sep 29.
Artículo en Inglés | MEDLINE | ID: mdl-20920215

RESUMEN

Familial hypocholesterolemia, namely abetalipoproteinemia, hypobetalipoproteinemia and chylomicron retention disease (CRD), are rare genetic diseases that cause malnutrition, failure to thrive, growth failure and vitamin E deficiency, as well as other complications. Recently, the gene implicated in CRD was identified. The diagnosis is often delayed because symptoms are nonspecific. Treatment and follow-up remain poorly defined.The aim of this paper is to provide guidelines for the diagnosis, treatment and follow-up of children with CRD based on a literature overview and two pediatric centers 'experience.The diagnosis is based on a history of chronic diarrhea with fat malabsorption and abnormal lipid profile. Upper endoscopy and histology reveal fat-laden enterocytes whereas vitamin E deficiency is invariably present. Creatine kinase (CK) is usually elevated and hepatic steatosis is common. Genotyping identifies the Sar1b gene mutation.Treatment should be aimed at preventing potential complications. Vomiting, diarrhea and abdominal distension improve on a low-long chain fat diet. Failure to thrive is one of the most common initial clinical findings. Neurological and ophthalmologic complications in CRD are less severe than in other types of familial hypocholesterolemia. However, the vitamin E deficiency status plays a pivotal role in preventing neurological complications. Essential fatty acid (EFA) deficiency is especially severe early in life. Recently, increased CK levels and cardiomyopathy have been described in addition to muscular manifestations. Poor mineralization and delayed bone maturation do occur. A moderate degree of macrovesicular steatosis is common, but no cases of steatohepatitis cirrhosis. Besides a low-long chain fat diet made up uniquely of polyunsaturated fatty acids, treatment includes fat-soluble vitamin supplements and large amounts of vitamin E. Despite fat malabsorption and the absence of postprandial chylomicrons, the oral route can prevent neurological complications even though serum levels of vitamin E remain chronically low. Dietary counseling is needed not only to monitor fat intake and improve symptoms, but also to maintain sufficient caloric and EFA intake. Despite a better understanding of the pathogenesis of CRD, the diagnosis and management of the disease remain a challenge for clinicians. The clinical guidelines proposed will helpfully lead to an earlier diagnosis and the prevention of complications.


Asunto(s)
Quilomicrones/metabolismo , Trastornos del Metabolismo de los Lípidos/diagnóstico , Trastornos del Metabolismo de los Lípidos/terapia , Síndromes de Malabsorción/diagnóstico , Síndromes de Malabsorción/terapia , Adulto , Antropometría , Niño , Preescolar , Estudios de Cohortes , Diarrea/complicaciones , Ácidos Grasos/metabolismo , Femenino , Trastornos del Crecimiento/complicaciones , Humanos , Lactante , Trastornos del Metabolismo de los Lípidos/complicaciones , Trastornos del Metabolismo de los Lípidos/genética , Síndromes de Malabsorción/complicaciones , Síndromes de Malabsorción/genética , Masculino , Desnutrición/complicaciones , Proteínas de Unión al GTP Monoméricas/genética , Proteínas de Unión al GTP Monoméricas/metabolismo , Mutación , Enfermedades del Sistema Nervioso/complicaciones , Deficiencia de Vitamina E/complicaciones
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA